TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Postoperative adverse outcome
Endpoint domain: Adverse events/effects
Primary endpoint: MicroRNA profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of mutations in ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ctDNA methylation pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Steroid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Coefficients of Variation (%CV) of FA measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uric acid to HDL-c ratio (UHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ocular pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax (maximum concentration of a drug in plasma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cephalometric radiographs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of children who enroll in a designated early childhood special education (ECSE) program or Chicago Public School
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of children who receive school-based therapies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Timeliness of ECSE services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of children who complete each step of IEP process
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency, nature, intensity and duration of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of severity, duration, reversibility of dose-limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Fertilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blastulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ploidy status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitochondria status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of velocity of blood flow in cortical bone and in marrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of direction of blood flow in cortical bone and in marrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mass of serum ferritin molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reoperation or disability or death due to intracranial hemorrhage within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Change in HbA1c concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Achievement of ACR 20/50/70
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of Minimal Disease Activity (MDA) state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Vertical Tooth Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Speed of entrainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SARS-CoV2 viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acute Cellular Rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in wrinkle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in nasolabial fold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in skin laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Obstetrical labor and delivery experience
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Incidence of postoperative overt stroke
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction with the telehealth solution
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of moderate and severe hypoglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of diabetic ketoacidosis events
Endpoint domain: Adverse events/effects
Primary endpoint: PVA strip positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean number of parasomniac episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of blue/red ROI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (NPRS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Dallas pain questionnaire (DPQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Variation in immune response (PCP titers)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stroke-related disability assessed by the change in modified Rankin scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Stroke-related disability assessed by the change in Rivermead Mobility Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Stroke-related disability assessed by the change in Barthel Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Correlation between ultrasonographic parameters and modified Cormack and Lehane grading scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month progression-Free Survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Dysmenorrhea Symptom Interference Scale (DSI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Moos Menstrual Distress Questionnaire, Form C (MDQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression Anxiety Stress Scale mit 21 Items (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: German Version of Pain Self-Efficacy Questionnaire (FESS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of noradrenaline use during anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of cardiac output changes during anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VAS knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Adverse Event (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Suicidality as assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Cognitive Impairment as Assessed by the Mini-Mental State Examination (MMSE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of women choosing effective contraceptive methods
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Balance and standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful sedation in Upper Gastrointestinal Endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Natural logarithm of reactive hyperemia index (Ln-RHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2 year overall survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Female Sexual Function Index (FSFI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Couple Satisfaction Index-16 (CSI-16)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self reported questionnaire on dyspareunia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of device related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Total Morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary vascular obstruction index (PVOI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child Salivary Cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Muscle Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting oxygen saturation (%) at altitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygen saturation during exercise at altitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Absolute change in the level of serum Cystatin C (Cys C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Physician Reported Cosmesis
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of problem behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Variation in HbA1c values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in German version of the Irrational Procrastination Scale (IPS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Academic Procrastination State Inventory (APSI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Culture results of skin swabs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of time of glucose levels below 3.9 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PICS-p at 2 months post-PICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patient accrual
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of radiotherapy related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Children's Depression Inventory, Second Edition, Parent Report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's Depression Inventory, Second Edition, Self Report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's Depression Rating Scale, Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relative time of same device settings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Time Curve From Zero to the Last Quantifiable Concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Plasma Concentration Time Curve From Zero to Infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma (peak) Drug Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early and midterm outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to normal daily activities within 3 days postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to Return to Work Among Employed Subjects
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Device or Procedure related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Musculoskeletal system assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Numerical Rating Scale (NPRS-11)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global Rating of Change scale (Patient Satisfaction)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of days between initial excision and split-thickness skin grafting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of sessions attended
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of days with completed monitoring
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Weight change from delivery to 4 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical efficacy of ibuprofen after molar tooth extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FQoR-15 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bacterial Quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Responders Achieving Target Calcium Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mortality (28-day)
Endpoint domain: Mortality/survival
Primary endpoint: Hospital-Acquired Infection (28-day)
Endpoint domain: Adverse events/effects
Primary endpoint: Organ Failure Resolution (28-day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute rate of mitral isthmus block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recovery rate of the mitral isthmus line
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: FLS score post-training session
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of the hierarchical clinical event composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average daily total activity counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arrest of the SJS/NET progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of vessels planned for surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of vessels found during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Significant cataract formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Clinical assessment of warts curement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of gastrojejunostomy ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area under the concentration-time curve from time 0 to 24 hours (AUC0-24h) on day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent clearance and apparent volume of distribution of centanafadine on Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with treatment-emergent Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentages of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Scalp Itch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of microneedle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell Viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apoptosis Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug use frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine assay for drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Military to Civilian Transition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children Participation Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Physicians' Global Severity Scale assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident amputation rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of teeth that fail
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Ankylosis (replacement resorption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of root resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of first pass effect (FPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed overall response rate (ORR) per RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of treatment emergent adverse events (TEAEs) leading to study drug discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of treatment emergent >= Grade 3 clinical laboratory abnormalities as assessed by CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes from baseline in vital signs, ECGs and laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Successful Toileting Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variation of pre-transplant status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total length of pressure center displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Displacement speed of the center of pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net leg phenylalanine release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CAUTI
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of secondary infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical outcomes based on treatment appropriateness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of immune suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage estimation of mortality
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants with early neurological impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean daily blood glucose-to-ketone ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subcutaneous elastic modulus with shear wave elastography (SWE) imaging of lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D general quality of life scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Central Cornea Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thinnest Point Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lens Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requiring oxygen supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: patient recruitment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: adherence to intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: withdrawal from study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: questionnaire data
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rate of unintentional unblinding
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Mean Change in Blood Oxygen-level Dependent (BOLD) Scores During Modified Go/No-Go Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disability of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall completion of counseling sessions and questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Characterization of immune cell phenotype and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pro QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Low-density Lipoprotein Cholesterol (LDL-C) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subject incidence of adverse events for XZP-6019 versus placebo
Endpoint domain: Adverse events/effects
Primary endpoint: venous thrombosis or pulmonary embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Efficacy in treatment of pigmented post acne scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in PPD - Probing Pocket Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes